severe cases – Page 15 – Communicable Diseases Research

Association Between S100b Levels and COVID-19 Pneumonia: A Case Control Study

S100b 수준과 COVID-19 폐렴 간의 연관성: 사례 대조 연구

Article

Published on 2021-09-012022-09-11
Journal: In vivo (Athens, Greece) [Category] SARS, 바이오마커,

Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy

이탈리아의 초기 전염병 기간 동안 COVID-19 환자의 치명적인 결과와 관련된 독특한 대사 프로필

Observation

Published on 2021-09-012022-09-10
Journal: Microbiology Spectrum [Category] MERS, SARS, 바이오마커, 진단,

[키워드] alteration best change clinical condition Cohort Complete contribute coronavirus disease Coronavirus disease 2019 country COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients described Diagnosis diagnostic disease severity epicenter Fatal outcome identify independent Infection IRCCS Italian Italy lombardy metabolic metabolome metabolomics moderate moment mortality rate not correlated outcome oxygen oxygen demand pandemic Potential biomarker potential biomarkers predictive biomarkers profile Prognosis Prognostic factor Region SARS-COV-2 infection severe cases severe symptom severity starting point the disease the patient therapeutic Therapeutic treatment understanding unique
[DOI] 10.1128/Spectrum.00549-21 PMC 바로가기 [Article Type] Observation

Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey

유럽 자가면역간질환 환자의 코로나19 유병률: 환자 중심의 온라인 설문조사

Article

Published on 2021-09-012022-09-11
Journal: United European gastroenterology journal [Category] SARS, 치료기술,

[키워드] (AILD) admitted to ICU advanced liver disease age Autoimmune autoimmuneliver disease Care chronic liver disease cirrhosis comparable country COVID-19 COVID-19 cases COVID-19 in patient data entry diagnosed with COVID-19 elevated Europe European Evidence FIVE France General population Germany highest identify incidence Limited liver Liver cirrhosis Liver disease Liver transplantation Medical care Mortality Netherland nine no difference no differences non-COVID-19 cases one patient online survey pandemic participant Participants Patient period prevalence platform Prevalence prevalence of COVID-19 registry required Result risk risk factor Risk factors risk of COVID-19 SARS-CoV-2 SARS-CoV-2 pandemic selection bia Selection bias severe cases Sex Spain stages status Status post union United Kingdom Ventilation was collected were excluded
[DOI] 10.1002/ueg2.12100 PMC 바로가기 [Article Type] Article

Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients

COVID-19 환자에서 NLR, LMR, PLR 및 LCR 비율의 예후 역할 평가

Article

Published on 2021-09-012022-09-11
Journal: Journal of medical virology [Category] SARS, 바이오마커,

Recovery of a patient with severe COVID-19 by acupuncture and Chinese herbal medicine adjuvant to standard care

침술 및 중국 약초 보조제에 의한 심각한 코비드 -19 환자의 회복 표준 치료

Case Reports

Published on 2021-09-012022-08-31
Journal: Journal of integrative medicine [Category] MERS, 치료제,

[키워드] Absorption accelerate acupuncture addition adjuvant adjuvants breath breathing function C-reactive protein Case report Chest computed tomography Chinese Chinese herbal medicine Combination Computed tomography contagious coronavirus disease Coronavirus disease 2019 COVID-19 CRP decrease dosage effective therapy female heart rate herbal medicine Integrative therapy lesion life-threatening Lung infection lymphocyte MLR monocyte neutrophil NLR Older oxygen Patient peripheral oxygen saturation rescue seeking Severe case Severe case. severe cases severe COVID-19 Shortness of breath significantly standard care the patient therapy treated was increased Wuhan Wuhan, China
[DOI] 10.1016/j.joim.2021.06.001 PMC 바로가기 [Article Type] Case Reports

COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study)

Neurology and Preclinical Neurological Studies - Original Article

Published on 2021-08-272022-10-29
Journal: Journal of neural transmission (Vienna, Austria : [Category] COVID-19, MERS, SARS,

[키워드] 95% CI adjusted hazard ratio adjusted odds ratio Associated symptom clinically cohort study conducted Confirmed COVID-19 infection COVID-19 COVID-19 patients critical cases determine Effect hospital Hospital admission hospitalized COVID-19 patient hospitalized patient ICU ICU admission increase Infection intensive care unit admission manifestation MCC Mild Mortality Neurological symptom New-onset neurological symptoms outcome Patient protocol Region Registration Respiratory failure retrospective Retrospective study risk Severe case severe cases significantly significantly higher significantly increased ventilator website with COVID-19
[DOI] 10.1007/s00702-021-02400-5 PMC 바로가기 [Article Type] Neurology and Preclinical Neurological Studies - Original Article

Comparative study on the clinical characteristics of local cases of COVID-19 and imported cases from abroad A retrospective cohort study

4900

Published on 2021-08-272022-10-30
Journal: Medicine [Category] COVID-19, MERS, SARS,

SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues

SARS-CoV-2는 수지상 세포를 손상시키고 조직에서 DC-SIGN 유전자 발현을 조절합니다

Article

Published on 2021-08-262022-09-12
Journal: International Journal of Molecular Sciences [Category] MERS, SARS, 진단,

Aortic arch thrombosis complicated by an embolic stroke in a patient with COVID-19: A case report

Case Report

Published on 2021-08-232022-10-28
Journal: Annals of Medicine and Surgery [Category] COVID-19,

Add-on effect of Chinese herbal medicine in the treatment of mild to moderate COVID-19: A systematic review and meta-analysis

경증에서 중간 정도의 Covid-19의 치료에서 중국 약초의 추가 효과 : 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-08-202022-09-10
Journal: PLoS ONE [Category] MERS, 치료제,

[키워드] 1.26 95% CI 95%CI Bia Biology CBM China Chinese CHM clinical CNKI combating combination therapy Controlled controlled trials conversion coronavirus disease Coronavirus disease 2019 cough COVID-19 COVID-19 cases COVID-19 pandemic cure rate database effective eligible Epidemic epidemiological Epidemiological investigations evaluate exclusion criteria Fever global pandemic help herbal medicine Inclusion inclusion and exclusion criteria Infrastructure journal Lung CT Medicine Meta-analysis Methodological quality Mild mild to moderate Mild to moderate COVID-19 moderate Moderate COVID-19 outbreak parameter participant Prevent progression proportion RCT RCTs Result review robust Safe Science searched selected sensitivity analysis Severe case severe cases shown significantly higher significantly lower statistical analysis Symptom systematic review TCM technology therapy treat Treatment Trial VIP was used WBC WBC count website Wuhan Wuhan, China
[DOI] 10.1371/journal.pone.0256429 PMC 바로가기 [Article Type] Meta-Analysis